Literature DB >> 2559007

Drug identification problems in two suicides with neuromuscular blocking agents.

G Somogyi1, M Varga, L Prokai, Z Dinya, L Buris.   

Abstract

Cases of suicide committed with neuromuscular blocking agents have been investigated. Both cases involved anesthesiologists who took the muscle relaxants suxamethonium chloride (Sukolin) or pipecuronium bromide (Arduan) and a rapid-acting barbiturate, 5-sec-butyl-5-ethyl-2-thiobarbituric acid (Inactin). The examinations were performed by using gas chromatography and mass spectrometry. The quantitative data obtained showed that doses useful in general anesthesiological practice were applied. Metabolites were found despite their fast metabolizing character.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559007     DOI: 10.1016/0379-0738(89)90153-9

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

1.  An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument.

Authors:  Kevin D Ballard; William E Vickery; Loan T Nguyen; Francis X Diamond; Fredric Rieders
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-02       Impact factor: 3.109

2.  Fall downstairs: accident, homicide or natural death?

Authors:  Burkhard Madea; Reinhard Dettmeyer; Frank Musshoff
Journal:  Forensic Sci Med Pathol       Date:  2007-10-02       Impact factor: 2.007

3.  Degradation and elimination of succinylcholine and succinylmonocholine and definition of their respective detection windows in blood and urine for forensic purposes.

Authors:  Uta Kuepper; Frank Herbstreit; Jürgen Peters; Burkhard Madea; Frank Musshoff
Journal:  Int J Legal Med       Date:  2011-09-24       Impact factor: 2.686

4.  Three homicides with darts tainted with succinylcholine: autopsy and toxicology.

Authors:  Jingjun Xing; Wenhe Li; Fang Tong; Yue Liang; Guanglong He; Yiwu Zhou
Journal:  Int J Legal Med       Date:  2016-05-14       Impact factor: 2.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.